{"preliminary_commentary":{"by_channel":{"x_thread":11,"youtube":1,"podcast":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT05508464\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"name":"ARREST 2","nct_id":"NCT05508464","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=arrest-2-nct05508464. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"ARREST2","arms":[{"description":"Standard or care palliative radiotherapy (includes the option for no treatment)","label":"Standard of Care","type":"ACTIVE_COMPARATOR"},{"description":"SABR to all tumors 6Gy x 5 over 3 weeks","label":"SABR","type":"ACTIVE_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2034-01-01","type":"ESTIMATED"},"conditions":["Metastatic Cancer"],"enrollment":{"count":138,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Arm 2: SABR","otherNames":[],"type":"RADIATION"},{"name":"Arm 1: Standard of Care","otherNames":[],"type":"RADIATION"}],"last_update":"2026-06-29","lead_sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","official_title":"Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial","overall_status":"RECRUITING","phases":["NA"],"primary_completion_date":{"date":"2034-01-01","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Overall Survival","timeFrame":"Time from randomization to death from any cause, patients followed for 5 years"}],"references":[],"start_date":{"date":"2023-10-16","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial","url":"https://clinicaltrials.gov/study/NCT05508464"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/arrest-2-nct05508464"}